NCT06245343 Investigation of the Effects of Functional Inspiratory Muscle Training in Patients With Lung Cancer
| NCT ID | NCT06245343 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gazi University |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-05-15 |
| Primary Completion | 2026-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-05-15 with a primary completion date of 2026-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients' pulmonary functions and diffusion capacity worsen following lung cancer surgery. Diaphragmatic activity and lung compliance decrease due to surgery. Peripheral and respiratory muscle functions are impaired in patients with lung cancer, exercise capacity and physical activity level decreased. Patients have postural instability and balance problems. Inspiratory muscle training has increased inspiratory muscle strength in patients with lung cancer. However, there is no study investigating functional inspiratory muscle training in patients with lung cancer.
Eligibility Criteria
Inclusion Criteria: 1. Patients aged 18-80 years with lung cancer 2. Patients who have undergone surgical treatment (wedge resection, segmentectomy, lobectomy, bilobectomy) for lung cancer 3. Lung cancer treatment completed, in remission and under follow-up Exclusion Criteria: 1. According to the American Association of Sports Medicine (ACSM) with absolute and relative contraindications to exercise tests 2. Patients who are having comorbidities such as uncontrolled hypertension, diabetes mellitus, heart failure or atrial fibrillation 3. Patients who are having acute infection during evaluation 4. Patients who are having orthopedic, neurological, psychological, etc. problems that limit evaluations
Contact & Investigator
Gülsüm SERTTAŞ GÜVEN, MSc.
STUDY CHAIR
Gazi University
Frequently Asked Questions
Who can join the NCT06245343 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06245343 currently recruiting?
Yes, NCT06245343 is actively recruiting participants. Contact the research team at meralbosnak@gazi.edu.tr for enrollment information.
Where is the NCT06245343 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06245343 clinical trial?
NCT06245343 is sponsored by Gazi University. The principal investigator is Gülsüm SERTTAŞ GÜVEN, MSc. at Gazi University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.